Literature DB >> 25370791

Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells.

Yingjun Xie1, Yongsheng Yang1, Degang Ji1, Dan Zhang1, Xiaoxiao Yao1, Xuewen Zhang1.   

Abstract

The Piwi subfamily is one of two Argonaute family proteins, which are characterized by the presence of Piwi and Piwi‑Argonaute‑Zwille domains, and are well known for their role in RNA silencing. Hiwi, a human member of the Piwi subfamily, is restricted to the germ line, where it binds Piwi‑interacting RNAs and functions in stem cell self‑renewal and gametogenesis. Previous reports have indicated that abnormal Hiwi expression may be associated with a poor prognosis of numerous types of human cancer, including hepatocellular carcinoma (HCC). However, little is currently known about the oncogenic role of Hiwi in HCC. In the present study, it was confirmed that Hiwi is overexpressed at both the mRNA and protein level, in HCC specimens, as well as in MHCC97L and MHCC97H HCC cell lines. A lentivirus‑mediated small hairpin rna (shRNA) targeting Hiwi was constructed and used to infect MHCC97L and MHCC97H cells. Relative Hiwi mRNA and protein expression levels were determined by quantitative polymerase chain reaction and western blot analysis, respectively. Cell proliferation, migration and invasion were determined using cell count, scratch and Transwell assays, respectively. Hiwi mRNA and protein expression was significantly downregulated in HCC cells in response to transduction with the lentivirus‑mediated shRNA. Furthermore, the proliferative, migrative and invasive properties of the shRNA‑transduced cells were significantly decreased. Therefore, Hiwi downregulation mediated by shRNA, may reduce the proliferation and migration of HCC cells. These results indicate that Hiwi may have an important role in the progression of HCC and may be a target for anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370791     DOI: 10.3892/mmr.2014.2847

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  22 in total

1.  Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.

Authors:  GholamReza Karami Madani; Abolfazl Rad; Mehdi Molavi; Sima Ardalan Khales; Mohammad Reza Abbaszadegan; Mohammad Mahdi Forghanifard
Journal:  J Gastrointest Cancer       Date:  2018-12

2.  Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.

Authors:  Weikang Zhang; Hongliang Liu; Jieyun Yin; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Yi Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2016-09-14       Impact factor: 7.396

Review 3.  Piwi-interacting RNAs (piRNAs) and cancer: Emerging biological concepts and potential clinical implications.

Authors:  Wenhao Weng; Hanhua Li; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

4.  PIWIL1 promotes gastric cancer via a piRNA-independent mechanism.

Authors:  Shuo Shi; Zhen-Zhen Yang; Sanhong Liu; Fan Yang; Haifan Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-26       Impact factor: 11.205

5.  Hiwi Promotes the Proliferation of Colorectal Cancer Cells via Upregulating Global DNA Methylation.

Authors:  Lin Yang; Lei Bi; Qingwei Liu; Meng Zhao; Bin Cao; Dong Li; Jianjun Xiu
Journal:  Dis Markers       Date:  2015-08-18       Impact factor: 3.434

Review 6.  The role of piRNA and its potential clinical implications in cancer.

Authors:  Carolina Baraúna Assumpção; Danielle Queiroz Calcagno; Taíssa Maíra Thomaz Araújo; Sidney Emmanuel Batista dos Santos; Ândrea Kely Campos Ribeiro dos Santos; Gregory Joseph Riggins; Rommel Rodriguez Burbano; Paulo Pimentel Assumpção
Journal:  Epigenomics       Date:  2015-05-01       Impact factor: 4.778

7.  PIWIL1 destabilizes microtubule by suppressing phosphorylation at Ser16 and RLIM-mediated degradation of Stathmin1.

Authors:  Chao Li; Xiaoyan Zhou; Jianhui Chen; Yilu Lu; Qianqian Sun; Dachang Tao; Wei Hu; Xulei Zheng; Shasha Bian; Yunqiang Liu; Yongxin Ma
Journal:  Oncotarget       Date:  2015-09-29

8.  Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.

Authors:  Zhangang Xiao; Jing Shen; Lin Zhang; Mingxing Li; Wei Hu; Chihin Cho
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

Review 9.  Epigenetic roles of PIWI proteins and piRNAs in colorectal cancer.

Authors:  Fatemeh Sadoughi; Seyyed Mehdi Mirhashemi; Zatollah Asemi
Journal:  Cancer Cell Int       Date:  2021-06-30       Impact factor: 5.722

10.  Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.

Authors:  Francesca Rizzo; Antonio Rinaldi; Giovanna Marchese; Elena Coviello; Assunta Sellitto; Angela Cordella; Giorgio Giurato; Giovanni Nassa; Maria Ravo; Roberta Tarallo; Luciano Milanesi; Anna Destro; Guido Torzilli; Massimo Roncalli; Luca Di Tommaso; Alessandro Weisz
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.